Lineage Cell Therapeutics (BT3.F) Q3 2025 Earnings

Aug 12Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.11
-0.08
-0.05
-0.02

Details

Expected EPS
-0.0228349521
Actual EPS
-0.111319
Surprise EPS
-0.09
Surprise Percent
-387.49%

Description

⁨Lineage Cell Therapeutics⁩ (⁦BT3.F⁩) has reported earnings of ⁦-0.111319⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts